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Resenosis after coronary intervention has remained a vexieg
problem despite the introduction of nearly 24 newer coronary
interventional devices. To more clearly evaluate the potential
Impact of three such new devices on restenosis, coronary lumen
diameters were measured before, immediately after and at 6
months after intervention, and restenosis was analyzed using
continuous geometric
techniques-
Loosen diameters were measured before and immediately after
intervention in 223 coronary vessels treated with one of three new
devices; a single Palmaz-Schatz stent (n = 87), directional atherec .
lorry (n = 125) and laser balloon angioplasty, (n =11)
;184 (1113%)
of the patients underwent follow-up angiography 6 months after
treatment. The immediate increase in lumen diameter produced
by the intervention (acute gain) and the subsequent reduction in
lumen diameter between the time of intervention to 6 month
follow-up study (late loss) were cxamined . For each of the three
interventions, the restenosis rate at follow-up study was analyzed
wing a traditional dichotomous definition (>_50% diameter steno-
sin), as well as a novel graphic technique .
Although the apparent resten oss rates differed signifleantly
among the three interventions (19% for stents, 31% for atheree-
Conventional percutaneous transluminal coronary angio-
plasty has continued to be troubled by an approximately 30%
incidence of restenosis within 6 months of an initially suc-
cessful procedure (1-3) . To address this and other limitations
of conventional angioplasty, nearly 24 newer devices for
coronary intervention (including stems, atherectomy cathe-
ters, laser balloon angioplasty catheters and ablative laser
catheters) are now in active clinical evaluation (4
-6) .
We
treated >200 patients with one of three such device ; during
the period from June 1988 through August 1990
. On the basis
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tomy and 50% for lose. balloon angioplasty; p = 0.02), late Ins
among the three interventions was equivalent (average 1 mm; p =
0.91). There were, however, marked differences in the acute gain
achieved by the threeinterventions : 2 .6 mm fm stems, 2.2 mm for
atherectomy, and 2 mm for laser balloon angioplasty ; p < 0.001).
It was these differences in acute gain rather than fate toss that
explained the observed differences in restenosis rate .
By using a continuous rather than a dichotomous view of
restenosis and resolving long-term device results in the compo-
nents of acute gain and late loss, analysis of this patient set
provides unique insights into the potential role of these area
devices in reducing restenas, The absolute magnitude of late loss
in lumen diameter (reflecting local ;Miami hyperptasia) was
equivalent among the three devices and was greater than the late
loss previously reported for conventional balloon angioplasty,
Therefore, the ability of a newer device to reduce restenosis may
be
related more to its ability to provide the greatest acute gain in
lumen diameter, rather than the ability to reduce subsequent
intimal hyperplasla.
(J Awe Cell Cordial
1992;196493-9)
of 6-month angiographic follow-up study in 83% of these
patients, we sought to address two major questions . 1) Is
there any evidence that these devices have a lower incidence
of restenosis than that expected from conventional angio-
plasty? 2) If
so, what are the apparent mechanisms that
underlie the apparent interdevice differences in observed
restenosis rates .
Methods
Study padeets . All patients were enrolled in a device-
specific clinical protocol supervised by the Committee on
Clinical Investigation at Beth Israel Hospital . They were
selected for treatment with one of
the three investigational
catheters on the basis
of presence
of symptomatic myocar-
dial ischemia and the presence of restenosis after one or
more prior interventions (108 lesions, 48%) or lesion char-
acteristics (for example, ecce^olio, ostial or saphenous vein
graft lesions) thought to be unfavorable for conventional
dilation (143 lesions, 64%) (Table I)
. These new device
0735.1097971-5 .00
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Table 1 . Patient and Lesion Demographic and
Angiographic Characteristics
LAD = left anterior descending coronary artery ; LCx = left circumflex
coronary artery ; RCA = right coronary artery
; SVG = saphenous vein graft
.
procedures accounted for 14% of the 1,593
coronary inter-
ventions performed during the study period.
Coronary stem group. These patients were treated with
the Palmaz-Schatz balloon-expandable stent (Johnson &
Johnson Interventions] Systems) as previously described
(7).
In brief, the target lesion was crossed with a 0 .014-in .
(0.036-cm) guide wire and predilated with a conventional
3-mm balloon . The balloon catheter was then exchanged for
a balloon-mounted stent advanced through a protective
delivery sheath (except for the first 38 patients who were
treated with a sheathless delivery balloon [71) . The stem was
positioned and deployed by balloon inflation and expanded
urther with a larger balloon (up to 5 mm) as needed to match
stem diameter to that of the adjacent reference vessel
segment . The eight patients treated with multiple overlap-
ping (rather than single) stems early in our experience were
excluded from further analysis given the known twofold
higher incidence of restenosis at the stent overlap site (7) .
Stent placement was performed during infusion of
dextran-40 and systemic heparinization (activated clotting
time 29300 s), with concomitant administration of aspirin
(325 mg/day) and dipyridamole (200 mg/day)
. Heparin infu-
sion was continued until administration of warfarin (5 to
10 mg/day) increased the prothrombin time to 16 to 18 s, at
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which level it was maintained for 6 to 12 weeks to minimize
the risk of stent thrombosis before full endothelial covering .
None of the patients so treated in this study sustained acute
or subacute vessel thrombosis, as has been reported (8) in up
to 24% of patients receiving another type of coronary
stent .
Directional atherectomy group. These patients were
treated with the Simpson AtheroCath (Devices for Vascular
Intervention) as previously described (9). In brief, the target
lesion was crossed with aO .014-in. (0.036-cm) guide wire and
an appropriately sized atherectomy catheter (6F for vessels
53 mm and 7F for vessels between 3 and 4 mm in diameter)
was advanced across the lesion . Three to 15 passes were
performed until the desired lumen diameter was achieved or
no further plaque could be retrieved. The procedure was
performed under systemic heparinization, with concomitant
aspirin and dipyridamole
therapy, as described for the
coronary stent group .
Laser balloon angioplasty group. These patients were
treated with the Spears laser balloon catheter (USCI) (10).
After predilation with a conventional balloon, the laser
balloon (inflated diameter 3 to 3 .5 mm) was positioned and
inflated to 60 psi as previously described (10) . After delivery
of 15 to 30 W for 20 s, the artery was allowed to "cool
down" for 30 s, at which time the balloon catheter was
deflated and removed . Ten patients treated on an emergency
basis with the laser balloon for the reversal of abrupt closure
caused by conventional angioplasty were excluded .
Acute and short-term outcome analysts. Criteria for de-
vice success included passage of the device, a residual
diameter stenosis s50% and the absence of a major compli-
cation (death, Q wave myocardial infarction or emergency
bypass surgery) . Only two patients sustained any of these
major complications (one patient after atherectomy and one
after an unsuccessful attempted stem placement required
emergency surgery) . Successfully treated patients were en.
couraged to undergo serial exercise testing at 1, 3 and 6
months after the procedure and repeat coronary angiography
at 6 months or if indicated clinically . However, angiographic
studies that did not show restenosis (diameter stenosis
2950%) were included only if performed >4 months after the
index procedure. Results from the first 37 patients who
received a stem (7), the first 76 patients who underwent
atherectomy (9) and the 11 patients who underwent laser
balloon angioplasty (10) have been reported previously.
Both the acute (pre- and postprocedure) and 6-month
(follow-up) angiograms were analyzed by using optically
magnified images . The minimal lumen diameter of each
treated lesion was measured by using the known diameter of
the angiographic catheter (11,12) .
The reference size was
taken as the mean of the diameter of the vessel segments
proximal and distal to the treated lesion. On the basis of
these measurements, two important variables were
derived.
Acute gain was defined as the increase in the absolute
diameter of the treated segment immediately after the pro-
cedure. Late
loss was defined as the decrease in absolute
diameter of the treated segment from the postprocedure to
Stems Atherectomy
Laser Balloon
Angioplasty
Lesions (no .) 87 125 11
Patient age (yr) 5B t 11 57 `0 11 61 -_ 9
% Male 83 83 82
Vessel treated (%I
LAD 18
66 55
RCA 47 13
36
LC.
6 7 9
SVG 29 14 0
Prior restenosis (%) 62 43 0
Lesion morphology 1%)
Eccentric 29 72 64
Usual 0 9
0
Device success (%) 99 92
100
[amen diameter (met)
Baseline
Rererenee 3 .35 t 0 .31 3 .09 ± 0.69 2 .78 ± 1 .89
Lesion 0 .81 t 0 .6 0.68 t 0.38 0 .45 t 0.25
% Ssenosis 77 t 16 78
t
11 84 t 9
Lesion length 6 .95 t 3 .31 6.61 ± 3.3 3 .82 ± 1 .89
Postprocedure
Lesion 3 .38 ± 0 .62 2.90 ± 0
.57 2 .43 t 0.29
% Stenosis -1%
t
13 6%
t
15 15%
t
t0
Acute gain 2 .57
t
0.77 2.22
t
0.63 1 .98 0 0.42
Follow-up
Lesion 2 .35 t 0.92 1 .86 t 0.% 1 .46 t 0.82
% Stenosis 29 t 25 37 t 29 50 ± 26
Late loss 1 .08 t 1 .06 1 .02 t 0.96 0.99 t 0.76
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the 6-month follow-up angiogram . The long-term net gain
produced by an intervention is thus the difference between
its acute gain and late loss .
Statistics. Clinical data and the coronary dimensions
were reported as mean value ± SD. Immediate and follow-
up results were compared by using analysis of variance . A n
value <0 .05 was considered significant . The distribution of
late loss for the entire group was tested for normality by the
Kolmogorov-Smirnov test : distributions were displayed by
histogram .
Results
Device success . Device success was obtained in 95 i of
235 lesions: 87 (99%) of 88 stems. 125 192%) of 136 athcrec-
tomy procedures and I I (100%) of I1 laser balloon proce-
dures. Six-month angiographic follow-up data were available
in 184 (83%) of the 223 successfully treated vessels 190% of
stem
. 77% of atherectomy and 100% of laser balloon angio-
plasly lesions) . The distributions of percent diameter steno-
sis before and after treatment and at the time of follow-up
angiography in each group are shown in Figure I
.
These follow-up data may also be displayed as a cumu-
lative frequency distribution, normalized to 100% of each
type of lesion to correct for different numbers of lesions
treated (Fig. 2A). This plot shows the overall rate of reste-
nosis (defined as late diameter stenosis a50%l to be 279c.
Restenosis rates for the individual devices, however, varied
significantly (19% for stents . 31% for directional atherec-
tomy and 50% for laser balloon angioplasty : o = 0.021 as
reflected by the disparate cumulative frequency distribution
plots for the different devices (Fig . 2B).
Acute gain and late less for each device . Because late
lumen diameter (and restenosis) are dependent on both the
increase in lumen diameter immediately after the procedure
and the magnitude of intimal response over the ensuing
months, we then examined data pertaining to the acute gain
and late loss for each device (Table I, Fig
. 3) . Stenting
produced the greatest acute gain of 2 .6 mm (increase in
lumen diameter from 0.8 to 3.4 mm . reference diameter
3.4 mm), with a subsequent late loss of I mm (decrease from
3
.4 to 2 .4 mm). Atherectomy produced an acute gain of
2.2 mm (increase from 0.7 to 2.9 mm. reference diameter
3.1 mm), with a subsequent late loss of I mm (decrease from
2.9 to 1.9 mm) . Laser balloon angioplasty produced the
smallest acute gain of 2 mm (increase from 0.5 to 2,4 mm .
reference diameter 2.8 mm) . with a late loss of t mm
(decrease from 2
.4 to 1
.5 mm)
. Although there were signifi-
cant (p < 0.001) differences in acute gain, late loss was
equivalent (p = 0.91) among the three devices
.
Given the identical average late losses among the three
devices, a histogram of late loss for all lesions was con-
structed (Fig
. 4)
. demonstrating that late loss is continuously
and normally distributed (p = 0.99, probability of nonnormal
distribution). The potential differences in late loss based on
the specific device used, reference artery size . acute gain .
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Figure I . Holograms demonstrating the normal distribution of
percent feno,is before IAt and after IOt intervention (stealing .
atherecnamv and laser balloon ungionlastyl in 223lesi~ns and in 184
lesion, at h-mnnlh follow : ui : after intervention ICI . The distribution
in C is broader and more rightwardly skewed compared with that in
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lesion morphologic characteristics, patient demographics
and prior restenosis could not be evaluated further because
of inadequate sample size for multiple analysis .
Discussion
Coronary restenosis . Conventional balloon angioplasty
continues to be plagued by a relatively high (30% to 40%)
incidence of restenosis
(1-3) and certain patient or lesion
subgroups (prior restenosis . "type B lesion" [for example,
eccentric or ostial], long lesions, total occlusion or vein graft
stenoses) appear to have restenosis rates approaching 50%
(13) .
No alteration in dilation technique or concomitant
o .to
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Figure 2, Definition-independent view of restenosis . A, Per-
cent stenosis at 6-month follow-up study from Figure IC is
displayed as a cumulative distribution of all lesions . Starting
at the most severe (100%) slenoses, the value on the ordinate
represents the percent of lesiors with a stenosis at follow-up
angiagraphy that is greater than the corresponding value on
the abscissa . With this graph, any definition of percent
stenosis can be selected to calculate the corresponding per-
cent of the study group that would qualify for restenosis by
that definition . If a >50% stenosis definition is used, 27% of
the study group is seen to have restenosis. B, Display of
definition-independent restenosis curves for the individual
devices
. Significant differences in restenosis rates there de-
fined as >50% stenosis) are evident (50% for laser balloon
angioplasty (LBA], 31% for atherectomy and 19% for stems),
but the uniform differences among the three devices in their
cumulative stenosis distributions at 6-month follow-up study
are also evident .
medical therapy has yet been shown conclusively to reduce
the incidence of restenosis
(14) .
The observed rate of restenosis may vary, depending on
the patient or lesion groups treated, as well as on which
definition of restenosis is employed (15,16) . Clinical reste-
nosis, defined as recurrent angina or exercise test evidence
of ischemia, is neither sufficiently sensitive nor specific for
rigorous analysis and may be confounded by the presence of
collateral flow, prior infarction or other diseased vessels
(17)
.
Even ungiographic restenosis may be misleading when
the restudy rate is <75% because disproportionate follow-up
data may lead to selection bias (]8). Moreover, the observed
angiographic restenosis rate may vary, depending on
Ad-."
Figure 3. Stacked bar graphs compare the average lumen
diameter before intervention (Pre), after intervention (Post)
and at follow-up study (FU) with reference artery size (Ref)
among the three devices and co eentionat angioplasty
(PTCA, Nohuyoshi et al . 123])
. Acute gain is defined as the
immediate improvement in lumen diameter provided by the
9 intervention, whereas late loss is the subsequent reduction in
g lumen diameter at 6-month follow-up study
. (The reference
~'
diameter is not displayed for stents because the average
postprocedure diameter was actually larger than the refer-
ee diameter
.) Late loss (stippled bar) is seen to be equal
among the three interventions and twice as great as that seen
after conventional angioplasty . LBA = laser balloon angio-
plasty .
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Figure 4. Histogram distribution of late loss in 184 lesions restudied
at 6 months after treatment with the new devices. All three inter-
ventions are pooled given their equivalent late loss . The normal
distribution of late loss is apparent .
whether visual or measured stenosis severity estimates are
used (19) and which definition of restenosis is applied . In
common use arc the National Heart. Lung . and Blood Institute
IV definition (loss of 50% of the acute gain produced by the
procedure) (16.20) or the Thomxcenter definition (loss of
0.72 mm of absolute lumen diameter after the procedure [twice
the standard deviation for repeat determinations of arterial
diameter obtained with their measurement system) (211 .
Because new devices generally produce better acute
results than does conventional angioplasty. both of the
commonly used angiographic definitions (16.20.21) may
identify some patients as having restenosis- who have com-
paratively mild (<50% stenosis) lesions at the time of
follow-up angiography
. Therefore, some centers have pre-
ferred to define restenosis as a late diameter stenosis a50%
relative to the reference segment (22). In our analysis . we
sought to avoid these pitfalls by obtaining a high (83%) level
of angiographic follow-up data . using digital caliper measure-
ments of
optically magnified images and developing a novel
("definition-independent") graphic method for displaying
the late behavior of different groups of patients (Fig. 2). This
graphic analysis (and application of the traditional dichoto-
mous definition of >50% stenosis) shows that single stents
are associated with a lower incidence of restenosis than is
either atherectomy or laser balloon angioplasty in this non-
randomized series of patients .
Differences in restenosis with the three devices
. In part,
the observed differences in restenosis may relate to differ-
ences in the patients treated with individual devices . For
example, laser balloon angioplasty was performed solely on
new stenoses, whereas the majority of stents were placed in
patients who had prior restenosis . Although all patients had
focal disease of arteries >2 .5 mm and the majority had at
least one unfavorable characteristic for subsequent resleno-
xyNTY tJ At . .
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sis (prior restenosis . eccentricity . saphenous graft location) .
other disparate patient characteristics preclude conclusive
comparison, of device-specific restenosis rates . They do
not . however. compromise the analysis of late lumen diam-
eter in terms of acute gain and late loss given the uniform
behavior of the three devices in this model .
Late loss in lumen diameter with the three devices . The
central question then becomes whether the apparent differ-
ence in the incidence of restenosis among devices was due to
differences in the amount of late loss . A number of postmor-
tem and in vivo atherectomy analyses 19 .23 241 have con-
firmed that intimal hyperplasia (smooth muscle cell migra-
tion . proliferation and matrix synthesis) is the major
contributor to the progressive lumen reduction that takes
place after successful dilation . Some such reduction in
lumen diameter has been noted in virtually all patients
restudied after angioplasty 12 .131 . Although no drug regimen
has yet conclusively reduced restenosis- it was hoped that
the nets devices in question (stents
. atherectomy and laser
balloon angioplasty catheters) would provide a smoother
lumen surface less stimulatory of subsequent intimal hyper-
plasia . If. however . the magnitude of this hyperplasia is
reflected by the late loss in lumen diameter that takes place
between the posttreatment and 6-month follow-up
a ngio-
grams . i t is clear that each of the three new technologies
studie•1 actually triggered more average late loss (I mml than
has typically been seen after conventional balloon angio-
plasty 10 .4 mm) 112) . This outcome should not be unex-
pected given greater vessel deformation with the new de-
vices and the potential mitogenic stimulus resulting from
implantation of a metallic stent . exposure of deep wall
components by atherectomy or thermal denaturation of
proteins by laser balloon angioplasty
.
Acute gain in lumen diameter with the three devices . If the
observed differences in restenosis rates seen among these
devices were not due to differences in late loss, they must
have been the result of the differences in acute gain 11 .7 to
2 .7 mm)
. The acute gain with conventional angioplasty is
generally limited to 1 .2 mm . leaving an average residual
stenosis of 30% after successful conventional angioplasty
(1 .13). This limitation is primarily due to pronounced elastic
recoil of the vessel after balloon deflation (25), which may
negate >1 mm of the potential lumen diameter present
during full balloon inflation
. Attempts to overcome this
limitation by the use of larger balloon diameters (balloon!
artery ratio >1
.1 :1) tend to increase dissection and abrupt
vessel closure (26) .
In contrast, all three newer devices achieved greater
acute gain than does conventional angioplasty, resulting in a
very low postprocedure percent stenosis
: -11% for stents.
6% for atherectomy and 15% for laser balloon angioplasty .
This improvement in acute gain may be due to reduction in
elastic recoil by metallic stenting and laser balloon welding
or to plaque removal by directional atherectomy
(27). More-
over. these devices appear to be able to achieve their larger
acute gains without a corresponding increase in the inci-
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dente of major complications (7 .9.10) . When the resultant
acute gain is large enough (as is the 2
.7-mm gain with scent
placement), it appears to be able to offset the I-mm average
late loss, while still maintaining a large lumen diameter and
a favorably low (19%) overall restenosis rate at follow-up
study
. In contrast, smaller acute gains coupled •vith an
equivalent I-ndm late loss (Table 1) are reflected in corre-
spondingly higher rates of restenosis seen after athereclomy
(31%) and laser balloon angioplasty (50%) in this study .
Implications
. These observations have several important
implications for coronary intervention . First . there is still no
evidence that any of these new devices decrease the amount
of subsequent ; itimal hyperplasia observed with conven-
tional balloon angioplasty (in fact, they all seem to increase
intimal hyperplasia). Second . the ability of a device to
reduce restenosis appears to depend on its producing suffi-
cient immediate increase in lumen diameter )acute gain) to
offset the expected subsequent intimal hyperplasia (late
loss). These observations may prompt operators to achieve
the largest acute gains that can be obtained safely using their
particular new technology. Third . the persistent occurrence
of restenosis in 19% of stented lesions (which had an average
- 1% residual stenosis immediately after stenting), suggests
that no device will be able to further reduce the restenosis
rate unless it (or its concomitant pharmacotherapy) also
reduces the amount of late loss. Finally, the observation that
late loss is a ubiquitous and normally distributed phenome-
non suggests that we should begin to approach restenosis as
a continuous rather than a binary (restenosis/no restenosis)
outcome
. That approach may prove particularly valuable in
the analysis of future comparisons among devices, patient
categories or drug treatment regimens .
Limitations. This study has several potential limitations .
First, the use of measured late loss as a marker for the
amount of intintal hyperplasia has not been validated di-
rectly, although we have confirmed (9) the presence of
intimal hyperplasia during atherectomy of restenoses occur-
ring after each type of the studied interventions . Further-
more, although late loss after angioplasty may be the sum-
mation of intimal hyperplasia and elastic recoil, we
disregarded the contribution of the latter in our analysis of
these new devices . After stealing, we confirmed that mea-
sured late loss correlates well with direct measurement of
the intrastent filling defect seen at follow-up angiography (71,
and after laser balloon angioplasty, elastic recoil does not
appear to be significant because lumen diameters were equiv-
alent between immediate postprocedure and 24-h restudy (10) .
Although elastic recoil after atherectomy has not been
evaluated precisely, lumen enlargement is only partially due
to dila orn (27), and interruption of elastic components by
subintimal vessel wall excision may be common (9) .
Second, measurement of late loss at 6 months assumes
that all treated segments have reached their maximal nar-
rowing by that time
. Comparison of 6- and 12-month re-
studies in patients receiving a stent has demonstrated no
further reduction in lumen diar.eter after 6 months (Schatz .
JACC Val . 19. No. 7
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personal communication), a finding that parallels prior ob-
servations (2 .131 in consecutively studied patients undergo-
ing angioplasty . showing that intimal hyperplasia reaches :is
final thickness by 4 months . Earlier (<4-month) restudy of
seven symptomatic patients with restenosis in our study may
have truncated their potential late loss by the premature
development of clinical symptoms that triggered further
intervention . Intravenous nitrates were given to all patients
during their acute study only, but analysis showed no
difference in reference vessel diameter between the acute
and follow-up angiograms .
Third . the observed normal distribution of late loss and
the similarities in mean late loss among the three treatments
rest on the gross clinical similarities among the individual
patients treated, Pending completion of randomized trials, a
multivariable model could be developed to correct for char-
acteristics found to be significant determinants of late loss to
reduce the effect of the evident interdevice patient selection
biases . Such a model would require a much larger sample
size but is being pursued using multicenter data for conven-
tional angioplasty and newer devices . These differences in
lesion characteristics, however. compromise neither the
across-device application of our model (based on acute gain
and late loss) nor the conclusion that differences in resteno-
sis rates relate to differences in acute gain . In fact, the device
with the lowest apparent restenotic rate (the stent) had the
highest percent of prior restenotic lesions, whereas the
device with the highest apparent restenosis rate (laser bal-
loon angioplasty) was used only in new lesions.
Conclusions
. Detailed 6-month angiographic follow-up in
a cohort of patients treated with one of three investigational
technologies for coronary intervention at a single center
suggest a lower (19%) restenosis rate for stents compared
with rates obtained with directional atherectomy (31%) or
laser balloon angioplasty 150%) . These differences in appar-
ent restenosis rate do not seem to be the result of less inlimal
hyperplasia )late loss) in those with a steal because late loss
was similar (1 mm) for all three interventions, amounting to
more than twice that reported for conventional angioplasty .
Rather, the lower observed restenosis rate for stealing
appears to be the direct result of the larger posttreatment
lumen diameter achieved by stenting, which allows tolerance
of late loss in most patients without the generation of
angiographic restenosis (late diameter stenosis re50%( . This
approach to the analysis of restenosis may prove useful in
subsequent trials comparing devices, patient groups or drug
regimens . The observed lower restenosis rate in scented
lesions. however, will need to be confirmed by randomized
trials now underway
.
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